Fulgent Genetics Inc (FLGT)
Pretax margin
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | -51,964 | -189,115 | -163,723 | -167,209 | -174,085 | -62,351 | -67,454 | -39,002 | 184,025 | 368,312 | 526,324 | 612,074 | 677,300 | 752,973 | 657,148 | 560,561 | 291,684 | 65,026 | 2,780 | 352 |
Revenue (ttm) | US$ in thousands | 283,470 | 277,761 | 290,705 | 287,530 | 289,213 | 286,412 | 307,380 | 364,868 | 618,968 | 802,935 | 925,148 | 953,423 | 992,584 | 1,035,891 | 909,739 | 773,388 | 421,712 | 135,121 | 43,752 | 34,911 |
Pretax margin | -18.33% | -68.09% | -56.32% | -58.15% | -60.19% | -21.77% | -21.94% | -10.69% | 29.73% | 45.87% | 56.89% | 64.20% | 68.24% | 72.69% | 72.23% | 72.48% | 69.17% | 48.12% | 6.35% | 1.01% |
December 31, 2024 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $-51,964K ÷ $283,470K
= -18.33%
Fulgent Genetics Inc's pretax margin has exhibited significant fluctuations over the past few years, reflecting changes in its operating profitability. The trend shows a gradual increase from March 31, 2020, where the pretax margin stood at 1.01%, reaching a peak of 72.69% on September 30, 2021. This period of strong profitability was followed by a slight decline, with the pretax margin dropping to 45.87% by September 30, 2022.
However, the pretax margin experienced a more significant decline starting from December 31, 2022, falling into negative territory. The company posted negative pretax margins for several periods, hitting a low of -68.09% on September 30, 2024. This negative trend was eventually reversed by December 31, 2024, when the pretax margin improved to -18.33%.
The fluctuation in pretax margin suggests varying levels of operational efficiency and cost management within Fulgent Genetics Inc. It is crucial for the company to closely monitor and address the factors driving these fluctuations to maintain sustainable profitability in the future.
Peer comparison
Dec 31, 2024